MMP9 and asthma: MPs/NPs diminish the tight junction proteins, decrease trans-epithelial resistance, and increase the expression of cellular matrix metallopeptidase 9 (MMP9), leading to lung injury and lowering the ability for lung repair, contributing to the pathogenesis of several lung diseases, such as asthma, COPD, and acute respiratory distress syndrome.